Federal proposal to force drug prices in TV ads draws big response from pharma, others

Four pharma companies chimed in among the 146 official comments on the federal government’s plan to tag pharma TV ads with drug prices. Pfizer, Eli Lilly, Sanofi and Johnson & Johnson filed commentary, along with the industry’s leading trade association, PhRMA, during the 60-day period that ended in December.